Personalised medicine in asthma: time for action
Asthma is a heterogeneous disease comprising several phenotypes driven by different pathways. To define these phenotypes or endotypes (phenotypes defined by mechanisms), an unbiased approach to clustering of various omics platforms will yield molecular phenotypes from which composite biomarkers can...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
European Respiratory Society
2017-09-01
|
| Series: | European Respiratory Review |
| Online Access: | http://err.ersjournals.com/content/26/145/170064.full |